Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: A randomized, double-blind, placebo-controlled, multicenter clinical trial - Concepedia

Concepedia

Publication | Closed Access

Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: A randomized, double-blind, placebo-controlled, multicenter clinical trial

236

Citations

0

References

1994

Year

Jean-François Dhainaut, Alain Tenaillon, Yves Le Tulzo, Benoı̂t Schlemmer, Jean-Pierre Solet, Michel Wolff, Laurent Holzapfel, Fabrice Zéni, Didier Dreyfuss, Jean-Paul Mira,

Critical Care Medicine

Abstract

The studied platelet-activating factor receptor antagonist (BN 52021) seems to be a safe and promising treatment for patients with severe Gram-negative sepsis.